4.6 Article

The Development of the Brief Eating Disorder in Athletes Questionnaire

期刊

MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
卷 46, 期 8, 页码 1666-1675

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1249/MSS.0000000000000276

关键词

SCREENING; VALIDATION; INSTRUMENT; SPORTS; DISORDERED EATING

资金

  1. Oslo Sports Trauma Research Center
  2. Norwegian Olympic Sports Center (Olympiatoppen)
  3. Eastern Norway Regional Health Authority
  4. International Olympic Committee
  5. Royal Norwegian Ministry of Culture
  6. Norsk Tipping AS
  7. Norwegian Olympic Committee and Confederation of Sport

向作者/读者索取更多资源

Purpose: The objective of this study is to design and validate a brief questionnaire able to discriminate between female elite athletes with and without an eating disorder (ED). Methods: In phase I, 221 (89.5%) adolescent athletes participated in a screening including the Eating Disorder Inventory-2 (EDI-2) and questions related to ED. All athletes reporting symptoms associated with ED (n = 96, 94.1%) and a random sample without symptoms (n = 88, 86.3%) attended the ED Examination Interview. On the basis of the screening, we extracted items with good predictive abilities for an ED diagnosis to the Brief ED in Athletes Questionnaire (BEDA-Q) versions 1 and 2. Version 1 consisted of seven items from the EDI-Body dissatisfaction, EDI-Drive for thinness, and questions regarding dieting. In version 2, two items from the EDI-Perfectionism subscale were added. In phase II, external predictive validity of version 1 was tested involving 54 age-matched elite athletes from an external data set. In phase III, predictive ability of posttest assessments was determined among athletes with no ED at pretest (n = 53, 100%). Logistic regression analyses were performed to identify predictors of ED. Results: Version 2 showed higher discriminative accuracy than version 1 in distinguishing athletes with and without an ED with a receiver operating characteristics area of 0.86 (95% confidence interval (CI), 0.78-0.93) compared with 0.83 (95% CI, 0.74-0.92). In phase II, the accuracy of version 1 was 0.77 (95% CI, 0.63-0.91). In predicting new cases, version 2 showed higher diagnostic accuracy than version 1 with a receiver operating characteristic area of 0.73 (98% CI, 0.52-0.93) compared with 0.70 (95% CI, 0.48-0.92). Conclusion: The BEDA-Q containing nine items reveals good ability to distinguish between female elite athletes with and without an ED. The BEDA-Q's predictive ability should be tested in larger samples.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据